100 related articles for article (PubMed ID: 2502955)
1. Rioprostil, a new prostaglandin E1 analogue does not affect glucose homeostasis in healthy volunteers.
Eichler HG; Korn A; Businger JA; Waldhäusl WK
Arch Int Pharmacodyn Ther; 1989; 298():288-92. PubMed ID: 2502955
[TBL] [Abstract][Full Text] [Related]
2. Effect of rioprostil, an oral prostaglandin E1 (PGE1) analogue, on lower esophageal sphincter pressure and on the motility of the distal esophagus in healthy volunteers.
Baunack AR; Froese G; Demol P; Wargenau M; Ruoff HJ; Weihrauch TR
Z Gastroenterol; 1988 Apr; 26(4):199-203. PubMed ID: 3149082
[TBL] [Abstract][Full Text] [Related]
3. Prevention of the acetylsalicylic acid-induced changes of the gastric potential difference by the new synthetic prostaglandin E1 analogue rioprostil.
Demol P; Schmitz HD; Weihrauch TR; Kuhlmann J
Arzneimittelforschung; 1986 Sep; 36(9):1406-8. PubMed ID: 3098255
[TBL] [Abstract][Full Text] [Related]
4. [Rioprostil 600 micrograms at night: marked inhibition of nocturnal intragastric acidity in man].
Dammann HG; Rehner M; Walter TA; Müller P; Simon B
Z Gastroenterol; 1986 May; 24(5):245-9. PubMed ID: 3088858
[TBL] [Abstract][Full Text] [Related]
5. Effect of rioprostil, a methyl-prostaglandin E1, on plasma level and renal excretion of beta-acetyldigoxin.
Demol P; Wingender W; Kuhlmann J
Scand J Gastroenterol Suppl; 1989; 164():68-71; discussion 71-2. PubMed ID: 2510284
[TBL] [Abstract][Full Text] [Related]
6. Effect of rioprostil, a methylprostaglandin E1 analog, on basal and stimulated plasma pancreatic hormone levels in man.
Segers O; Somers G
Dig Dis Sci; 1990 Jan; 35(1):20-6. PubMed ID: 2104796
[TBL] [Abstract][Full Text] [Related]
7. Effects of rioprostil on the postprandial glucose, GIP, insulin and gastrin levels in volunteers.
Demol P; Wingender W
Scand J Gastroenterol Suppl; 1989; 164():112-7. PubMed ID: 2510253
[TBL] [Abstract][Full Text] [Related]
8. Influence of the prostaglandin E1 analogue Rioprostil on the human gastric mucosa.
Svendsen LB; Stener Jørgensen F; Hart Hansen O; Johansen A; Horn T; Larsen JK
Digestion; 1987; 37(1):29-34. PubMed ID: 3111919
[TBL] [Abstract][Full Text] [Related]
9. Selective gastric antilesion properties of rioprostil, a prostaglandin E1 analog, in rats and dogs.
Katz LB; Shriver DA; Tobia AJ; Rosenthale ME
J Pharmacol Exp Ther; 1987 Sep; 242(3):927-33. PubMed ID: 3116199
[TBL] [Abstract][Full Text] [Related]
10. Effect of rioprostil, 600 micrograms, on the interdigestive myoelectrical activity of the humans small intestine.
Vantrappen G; Janssens J
Scand J Gastroenterol Suppl; 1989; 164():133-8; discussion 138-9. PubMed ID: 2510257
[TBL] [Abstract][Full Text] [Related]
11. Effect of rioprostil, an oral prostaglandin E1 analogue, on lower oesophageal sphincter pressure and on the motility of the distal oesophagus in healthy volunteers.
Baunack AR; Demol P; Froese G; Kuhlmann J; Weihrauch TR
Scand J Gastroenterol Suppl; 1989; 164():120-5; discussion 125-6. PubMed ID: 2510255
[TBL] [Abstract][Full Text] [Related]
12. The antigastrolesive activity of rioprostil, a 16-methyl prostaglandin-E1 analogue in healthy volunteers.
Cohen A; Tolman KG; Lewis GP; Brown S; van Horn A; McCormack GH; Simon DM
Scand J Gastroenterol Suppl; 1989; 164():81-90; discussion 90-1. PubMed ID: 2510286
[TBL] [Abstract][Full Text] [Related]
13. Pharmacology of rioprostil, a new gastric cytoprotective/antisecretory agent.
Shriver DA; Rosenthale ME; Kluender HC; Schut RN; McGuire JL; Hong E
Arzneimittelforschung; 1985; 35(5):839-43. PubMed ID: 3927928
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic interactions between theophylline and rioprostil.
de Lauture D; Rey E; d'Athis P; Richard MO; Paccaly D; Prunieras F; Strauch G; Olive G
Scand J Gastroenterol Suppl; 1989; 164():63-6; discussion 67. PubMed ID: 2510283
[TBL] [Abstract][Full Text] [Related]
15. Effect of rioprostil on aspirin-induced gastrointestinal mucosal changes in normal volunteers.
Tolman KG; Detweiler MK; Harrison CA; Rollins DE; Simon DA; Brady C; McCormack GH; Bryant EC
J Clin Pharmacol; 1988 Jan; 28(1):76-80. PubMed ID: 3127431
[TBL] [Abstract][Full Text] [Related]
16. The interaction of the prostaglandin E derivative rioprostil with oral anticoagulant agents.
Thijssen HH; Hamulyàk K
Clin Pharmacol Ther; 1989 Jul; 46(1):110-6. PubMed ID: 2501056
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of gastric secretion in man by rioprostil, a new synthetic methyl prostaglandin E1.
Demol P; Wingender W; Weihrauch TR; Graefe KH
Arzneimittelforschung; 1985; 35(5):861-3. PubMed ID: 3927929
[TBL] [Abstract][Full Text] [Related]
18. Influence of chronic rioprostil treatment on gastric endocrine function.
Koop H; Schwarting H; Eckel U; Wagenknecht J; Hallfeldt U; Arnold R
Scand J Gastroenterol Suppl; 1989; 164():104-10; discussion 110-1. PubMed ID: 2573147
[TBL] [Abstract][Full Text] [Related]
19. Rioprostil, a new prostaglandin E1, prevents cyclosporin A-induced damage to endocrine and exocrine pancreas.
Müller M; Degenhardt H; Bergmann K; Coone H; Löhr M; Klöppel G; Goebell H
Scand J Gastroenterol Suppl; 1989; 164():35-41. PubMed ID: 2510278
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandins and peptic ulcer disease: nocturnal administration of rioprostil vs ranitidine in duodenal ulcer healing.
Simon B; Dammann HG; Müller P
Klin Wochenschr; 1986; 64 Suppl 7():44-6. PubMed ID: 3104657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
